QA  Emerging biotech Novoʼs Uli Stilz on biotech innovation and the future of diabetes drugs The Danish drugmakerʼs innovation hub in Boston has teamed up with the Broad Institute Mass General Brigham Harvard and Yale expanding its research into cardiometabolic diseases